GL1X · GenesisL1 explorer

MolNFT v2 · #122108 · protein

Structure of complement C5 in complex with eculizumab

5I5K: “Structure of complement C5 in complex with eculizumab”. X-ray diffraction at 4.2, 2 ligands (NAG, BMA). MolNFT v2 #122108 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
5I5K
Type
protein
Length
4,134 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
4.2
Source
Homo sapiens
UniProt
P01031
Ligands
NAG, BMA

Structure

x-ray diffraction · resolution 4.2 · 4 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
B—protein1634—P01031
H, X—protein221——
L, Y—protein213——
A—protein1632—P01031

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 4 copies · chains B, A
  • BMA · beta-D-mannopyranose · sugar · 2 copies

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5I5K · Structure of complement C5 in complex with eculizumab · the same entry in another collection · chain Y against Y, TM-score 1.00
  • P01031 · AlphaFold monomer V2.0 prediction for complement C5 (P01031) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.